Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 14, 2026 | HealthPartners | Natalizumab (Tysabri, Tyruko)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046241 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Mucopolysaccharidoses (MPS) drug therapy - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187828 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Mucopolysaccharidoses (MPS) drug therapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046050 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Medications for risk reduction of primary breast cancer in womenPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046044 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Medication therapy disease management programPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046043 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - lutetium Lu 177 dotatate (Lutathera)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-221636 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Lumasiran (Oxlumo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-234243 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Lefamulin (Xenleta) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-227134 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Laser treatment for skin conditionsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046029 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Investigational spine proceduresPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046448 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Intraosseous radiofrequency ablation of the basivertebral nervePayerPolicy · HEALTHPARTNERS-CC-ENTRY-274114 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Inpatient carePayerPolicy · HEALTHPARTNERS-CC-AENTRY-046138 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: vector-bornePayerPolicy · HEALTHPARTNERS-CC-ENTRY-282393 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: respiratoryPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282610 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: genitourinaryPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282389 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Inclisiran (Leqvio)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-248558 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Ibalizumab-uiyk (Trogarzo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-204624 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Ibalizumab-uiyk (Trogarzo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-202453 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | IV iron replacement therapyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-252172 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hyperbaric oxygen therapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045963 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hospital bedPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045960 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Home health servicesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045950 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hereditary angioedema (HAE) drug therapy - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187825 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hereditary angioedema (HAE) drug therapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045948 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Habilitative therapiesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046424 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | GnRH agonists for pubertal suppressionPayerPolicy · HEALTHPARTNERS-CC-ENTRY-197061 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Givosiran (Givlaari) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226837 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Givosiran (Givlaari)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-226973 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for recurrent respiratory papillomatosis: zopapogene imadenovec-drba (Papzimeos)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287011 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for metachromatic leukodystrophy: atidarsagene autotemcel (Lenmeldy)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-278017 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for inherited retinal dystrophy (Luxturna)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-200362 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for hemophilia B (Hemgenix, Beqvez)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-257856 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for hemophilia A (Roctavian)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267697 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for dystrophic epidermolysis bullosa (Vyjuvek, Zevaskyn)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267698 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for cerebral adrenoleukodystrophy (Skysona)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-258169 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for beta-thalassemia (Casgevy, Zynteglo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-258219 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for aromatic L-amino acid decarboxylase deficiency (Kebilidi)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-284475 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming surgery – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-236032 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fosdenopterin (Nulibry)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-235031 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Formula - amino acid based elemental - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045923 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Foot carePayerPolicy · HEALTHPARTNERS-CC-AENTRY-045922 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fluocinolone acetonide implants (Iluvien, Retisert and Yutiq)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-207224 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Filgrastim (Neupogen, Nivestym, Zarxio) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-228288 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fecal microbiota, live - jslm (Rebyota)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-257233 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fabry disease enzyme replacement therapy: agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-186765 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Eye surgery - refractivePayerPolicy · HEALTHPARTNERS-CC-AENTRY-045915 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Evinacumab-dgnb (Evkeeza)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-234244 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Eteplirsen (Exondys 51)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-191266 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Etelcalcetide (Parsabiv) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-202922 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Esketamine (Spravato) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-221632 | Criteria changed |
|---|